Karen Knudsen is appointed to the Paradigm Health Board of Directors
Karen Knudsen, Executive Strategic Advisor and Immediate Past CEO of the American Cancer Society (ACS), shared a post on LinkedIn by Paradigm Health, adding:
“If we are going to truly change the dynamic of increasing access to cancer clinical trials – the most advanced form of cancer care – we must think differently.
Of the more than 2 million Americans who will be diagnosed with cancer this year, only a small percentage will be enrolled in (or even asked about) a clinical trial. That has to change!
Paradigm Health (and their AI-driven approach) is tackling this challenge head-on, reducing friction points for both oncology teams and patients. By streamlining trial feasibility and enrollment, we help more people gain access to the potentially life-saving therapies.
I could not be more honored to have joined the Paradigm Health Board, and to bring my experience as a cancer center leader and health care executive to help shape the path forward.
More access. Better outcomes. Let’s get to work!”
Quoting Paradigm Health’s post:
“Paradigm Health is proud to announce the appointment of Karen Knudsen to our Board of Directors.
Dr. Knudsen is a globally recognized cancer scientist and executive leader who joins Paradigm Health following her successful term as Chief Executive Officer of the American Cancer Society (ACS) and its advocacy affiliate, ACS Cancer Action Network.
With extensive experience as Enterprise Director of the Sidney Kimmel Comprehensive Cancer Center (an NCI-designated center of excellence), service on the NCI Board of Scientific Advisors, and as President of the Association of American Cancer Institutes, Dr. Knudsen brings invaluable perspective to our mission.
We look forward to working with Dr. Knudsen to expand clinical trial access and make trials more economic and efficient for healthcare providers nationwide.
Read more in today’s update.”
More posts featuring Karen Knudsen.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023